Systems Biology of Interferon Responses
Publication: Journal of Interferon & Cytokine Research
Volume 31, Issue Number 1
Abstract
The interferons (IFNs) are a pleiotropic family of cytokines that perform fundamental functions in protecting host organisms from disease and in maintaining homeostasis. Like other multifunctional cytokines, excessive or inappropriate activity can cause toxicity and even death. Therefore, host organisms have evolved specific and highly regulated mechanisms to control the temporal and tissue specificity of production of IFNs and the selection of pathways and genes to be activated as the effectors of the IFN response in cells. There are now numerous microarray datasets available to enable a “global” analysis of the genes involved in the IFN response. This article describes the INTERFEROME database, which assimilates the available expression profiling data and its contents and enables the definition of IFN-regulated genes, discovery of pathways, regulatory networks, and tissue specificities of the IFN response.
Get full access to this article
View all available purchase options and get full access to this article.
References
Ashburner MBall CABlake JABotstein DButler HCherry JMDavis APDolinski KDwight SSEppig JTHarris MAHill DPIssel-Tarver LKasarskis ALewis SMatese JCRichardson JERingwald MRubin GMSherlock G2000. Gene ontology: tool for the unification of biology. The Gene Ontology ConsortiumNat Genet25125-29. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. 2000. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25(1):25–29.
Barrat FJMeeker TGregorio JChan JHUematsu SAkira SChang BDuramad OCoffman RL2005. Nucleic acids of mammalian origin can act as endogenous ligands for toll-like receptors and may promote systemic lupus erythematosusJ Exp Med20281131-1139. Barrat FJ, Meeker T, Gregorio J, Chan JH, Uematsu S, Akira S, Chang B, Duramad O, Coffman RL. 2005. Nucleic acids of mammalian origin can act as endogenous ligands for toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 202(8):1131–1139.
Chakrabarti AJha BKSilverman RH2010. New insights into the role of RNase L in innate immunityJ Interferon Cytokine Res31149-57. Chakrabarti A, Jha BK, Silverman RH. 2010. New insights into the role of RNase L in innate immunity. J Interferon Cytokine Res 31(1):49–57.
Conway DCohen JA2010. Combination therapy in multiple sclerosisLancet Neurol93299-308. Conway D, Cohen JA. 2010. Combination therapy in multiple sclerosis. Lancet Neurol 9(3):299–308.
Dearolf CR1999. JAKs and STATs in invertebrate model organismsCell Mol Life Sci55121578-1584. Dearolf CR. 1999. JAKs and STATs in invertebrate model organisms. Cell Mol Life Sci 55(12):1578–1584.
de Weerd NASamarajiwa SAHertzog PJ2007. Type I interferon receptors: biochemistry and biological functionsJ Biol Chem2822820053-20057. de Weerd NA, Samarajiwa SA, Hertzog PJ. 2007. Type I interferon receptors: biochemistry and biological functions. J Biol Chem 282(28):20053–20057.
Fitzgerald KA2010. The interferon inducible gene: viperinJ Interferon Cytokine Res311131-135. Fitzgerald KA. 2010. The interferon inducible gene: viperin. J Interferon Cytokine Res 31(1):131–135.
Gough DJMessina NLHii LGould JASabapathy KRobertson APTrapani JALevy DEHertzog PJClarke CJJohnstone RW2010. Functional crosstalk between type I and II interferon through the regulated expression of STAT1PLoS Biol84e1000361. Gough DJ, Messina NL, Hii L, Gould JA, Sabapathy K, Robertson AP, Trapani JA, Levy DE, Hertzog PJ, Clarke CJ, Johnstone RW. 2010. Functional crosstalk between type I and II interferon through the regulated expression of STAT1. PLoS Biol 8(4):e1000361.
Graham RRHom GOrtmann WBehrens TW2009. Review of recent genome-wide association scans in lupusJ Intern Med2656680-688. Graham RR, Hom G, Ortmann W, Behrens TW. 2009. Review of recent genome-wide association scans in lupus. J Intern Med 265(6):680–688.
Haller OKochs G2010. Human MxA Protein: an interferon-induced dynamin-like GTPase with broad antiviral activityJ Interferon Cytokine Res31179-87. Haller O, Kochs G. 2010. Human MxA Protein: an interferon-induced dynamin-like GTPase with broad antiviral activity. J Interferon Cytokine Res 31(1):79–87.
Hibino TLoza-Coll MMessier CMajeske AJCohen AHTerwilliger DPBuckley KMBrockton VNair SVBerney KFugmann SDAnderson MKPancer ZCameron RASmith LCRast JP2006. The immune gene repertoire encoded in the purple sea urchin genomeDev Biol3001349-365. Hibino T, Loza-Coll M, Messier C, Majeske AJ, Cohen AH, Terwilliger DP, Buckley KM, Brockton V, Nair SV, Berney K, Fugmann SD, Anderson MK, Pancer Z, Cameron RA, Smith LC, Rast JP. 2006. The immune gene repertoire encoded in the purple sea urchin genome. Dev Biol 300(1):349–365.
Hu XChung AYWu IFoldi JChen JJi JDTateya TKang YJHan JGessler MKageyama RIvashkiv LB2008. Integrated regulation of toll-like receptor responses by Notch and interferon-gamma pathwaysImmunity295691-703. Hu X, Chung AY, Wu I, Foldi J, Chen J, Ji JD, Tateya T, Kang YJ, Han J, Gessler M, Kageyama R, Ivashkiv LB. 2008. Integrated regulation of toll-like receptor responses by Notch and interferon-gamma pathways. Immunity 29(5):691–703.
Huang SHendriks WAlthage AHemmi SBluethmann HKamijo RVilcek JZinkernagel RMAguet M1993. Immune response in mice that lack the interferon-gamma receptorScience25951021742-1745. Huang S, Hendriks W, Althage A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkernagel RM, Aguet M. 1993. Immune response in mice that lack the interferon-gamma receptor. Science 259(5102):1742–1745.
Ishikawa HBarber GN2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signallingNature4557213674-678. Ishikawa H, Barber GN. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455(7213):674–678.
Jonasch EHaluska FG2001. Interferon in oncological practice: review of interferon biology, clinical applications, and toxicitiesOncologist6134-55. Jonasch E, Haluska FG. 2001. Interferon in oncological practice: review of interferon biology, clinical applications, and toxicities. Oncologist 6(1):34–55.
Khoo JJForster SMansell A2010. Toll-like receptors as interferon-regulated genes and their role in diseaseJ Interferon Cytokine Res31113-25. Khoo JJ, Forster S, Mansell A. 2010. Toll-like receptors as interferon-regulated genes and their role in disease. J Interferon Cytokine Res 31(1):13–25.
Kin TOno Y2007. Idiographica: a general-purpose web application to build idiograms on-demand for human, mouse and ratBioinformatics23212945-2946. Kin T, Ono Y. 2007. Idiographica: a general-purpose web application to build idiograms on-demand for human, mouse and rat. Bioinformatics 23(21):2945–2946.
Kotenko SVGallagher GBaurin VVLewis-Antes AShen MShah NKLanger JASheikh FDickensheets HDonnelly RP2003. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complexNat Immunol4169-77. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP. 2003. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 4(1):69–77.
Kristiansen HGad HHEskildsen-Larsen SDespres PHartmann R2010. The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activitiesJ Interferon Cytokine Res31141-47. Kristiansen H, Gad HH, Eskildsen-Larsen S, Despres P, Hartmann R. 2010. The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities. J Interferon Cytokine Res 31(1):41–47.
Mansell ASmith RDoyle SLGray PFenner JECrack PJNicholson SEHilton DJO'Neill LAHertzog PJ2006. Suppressor of cytokine signaling 1 negatively regulates toll-like receptor signaling by mediating Mal degradationNat Immunol72148-155. Mansell A, Smith R, Doyle SL, Gray P, Fenner JE, Crack PJ, Nicholson SE, Hilton DJ, O'Neill LA, Hertzog PJ. 2006. Suppressor of cytokine signaling 1 negatively regulates toll-like receptor signaling by mediating Mal degradation. Nat Immunol 7(2):148–155.
Marine JCTopham DJMcKay CWang DParganas EStravopodis DYoshimura AIhle JN1999. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethalityCell985609-616. Marine JC, Topham DJ, McKay C, Wang D, Parganas E, Stravopodis D, Yoshimura A, Ihle JN. 1999. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 98(5):609–616.
Noppert SJFitzgerald KAHertzog PJ2007. The role of type I interferons in TLR responsesImmunol Cell Biol856446-457. Noppert SJ, Fitzgerald KA, Hertzog PJ. 2007. The role of type I interferons in TLR responses. Immunol Cell Biol 85(6):446–457.
Pindel ASadler A2010. The role of protein kinase R in the interferon responseJ Interferon Cytokine Res31159-70. Pindel A, Sadler A. 2010. The role of protein kinase R in the interferon response. J Interferon Cytokine Res 31(1):59–70.
Platanias LC2005. Mechanisms of type-I- and type-II-interferon-mediated signallingNat Rev Immunol55375-386. Platanias LC. 2005. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5(5):375–386.
Ramana CVGil MPSchreiber RDStark GR2002. Stat1-dependent and -independent pathways in IFN-gamma-dependent signalingTrends Immunol23296-101. Ramana CV, Gil MP, Schreiber RD, Stark GR. 2002. Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling. Trends Immunol 23(2):96–101.
Sadler AJWilliams BR2008. Interferon-inducible antiviral effectorsNat Rev Immunol87559-568. Sadler AJ, Williams BR. 2008. Interferon-inducible antiviral effectors. Nat Rev Immunol 8(7):559–568.
Samarajiwa SAForster SAuchettl KHertzog PJ2009. INTERFEROME: the database of interferon regulated genesNucleic Acids Res37Database issueD852-D857. Samarajiwa SA, Forster S, Auchettl K, Hertzog PJ. 2009. INTERFEROME: the database of interferon regulated genes. Nucleic Acids Res 37(Database issue):D852–D857.
Stark GRKerr IMWilliams BRSilverman RHSchreiber RD1998. How cells respond to interferonsAnnu Rev Biochem67227-264. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. 1998. How cells respond to interferons. Annu Rev Biochem 67:227–264.
Starr RWillson TAViney EMMurray LJRayner JRJenkins BJGonda TJAlexander WSMetcalf DNicola NAHilton DJ1997. A family of cytokine-inducible inhibitors of signallingNature3876636917-921. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ. 1997. A family of cytokine-inducible inhibitors of signalling. Nature 387(6636):917–921.
Su AIWiltshire TBatalov SLapp HChing KABlock DZhang JSoden RHayakawa MKreiman GCooke MPWalker JRHogenesch JB2004. A gene atlas of the mouse and human protein-encoding transcriptomesProc Natl Acad Sci U S A101166062-6067. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, Cooke MP, Walker JR, Hogenesch JB. 2004. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 101(16):6062–6067.
Suppiah VMoldovan MAhlenstiel GBerg TWeltman MAbate MLBassendine MSpengler UDore GJPowell ERiordan SSheridan DSmedile AFragomeli VMuller TBahlo MStewart GJBooth DRGeorge J2009. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapyNat Genet41101100-1104. Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, Bassendine M, Spengler U, Dore GJ, Powell E, Riordan S, Sheridan D, Smedile A, Fragomeli V, Muller T, Bahlo M, Stewart GJ, Booth DR, George J. 2009. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 41(10):1100–1104.
Thomas DLThio CLMartin MPQi YGe DO'Huigin CKidd JKidd KKhakoo SIAlexander GGoedert JJKirk GDDonfield SMRosen HRTobler LHBusch MPMcHutchison JGGoldstein DBCarrington M2009. Genetic variation in IL28B and spontaneous clearance of hepatitis C virusNature461798-801. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, Goedert JJ, Kirk GD, Donfield SM, Rosen HR, Tobler LH, Busch MP, McHutchison JG, Goldstein DB, Carrington M. 2009. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461:798–801.
Wang JCampbell ILZhang H2008. Systemic interferon-alpha regulates interferon-stimulated genes in the central nervous systemMol Psychiatry133293-301. Wang J, Campbell IL, Zhang H. 2008. Systemic interferon-alpha regulates interferon-stimulated genes in the central nervous system. Mol Psychiatry 13(3):293–301.
Yao YRichman LHiggs BWMorehouse CAde los Reyes MBrohawn PZhang JWhite BCoyle AJKiener PAJallal B2009. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha antibody in systemic lups erythematosusArthritis Rheum6061785-1796. Yao Y, Richman L, Higgs BW, Morehouse CA, de los Reyes M, Brohawn P, Zhang J, White B, Coyle AJ, Kiener PA, Jallal B. 2009. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha antibody in systemic lups erythematosus. Arthritis Rheum 60(6):1785–1796.
Information & Authors
Information
Published In
Journal of Interferon & Cytokine Research
Volume 31 • Issue Number 1 • January 2011
Pages: 5 - 11
PubMed: 21226606
Copyright
Copyright 2011, Mary Ann Liebert, Inc.
History
Published online: 12 January 2011
Published in print: January 2011
Accepted: 8 September 2010
Received: 8 September 2010
Topics
Authors
Author Disclosure Statement
No competing financial interests exist.
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Get Access
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.